Article Text

Download PDFPDF
Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies
  1. É Toussirot1,
  2. P Saas2,
  3. J Pariset2,
  4. J Chabod2,
  5. P Tiberghien2,
  6. D Wendling1
  1. 1Department of Rheumatology, University Hospital Jean Minjoz, Bd Fleming, F-25030 Besançon, cédex France
  2. 2INSERM U645 UPRES EA2284, Établissement Français du Sang, IFR 133, Bd Fleming F-25030 Besançon, France
  1. Correspondence to:
    Dr É Toussirot

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Human leucocyte class I antigens (HLA-I) are expressed on the surface of all nucleated cells but can also be found in soluble forms. These soluble HLA-I (sHLA-I) molecules can be produced by either membrane shedding, proteolysis of the intact heavy chain, or by alternative splicing.1 They have been implicated in regulatory functions and have immunomodulatory properties.2 Increased levels of sHLA-I were found during graft rejections, in various infectious (cytomegalovirus, hepatitis B or C, HIV infection, active tuberculosis) and autoimmune diseases.3–6 In systemic lupus erythematosus and rheumatoid arthritis, levels of sHLA-I antigens correlate with disease activity.4,6 Spondyloarthropathies (SpA) are conditions closely linked to HLA-B27, a class I antigen. Thus, in this study, we evaluated the serum concentrations of sHLA-I antigens in a large cohort of patients with SpA.

One hundred and twenty three patients …

View Full Text